47 results
SC 14D9
PNT
POINT Biopharma Global Inc.
13 Oct 23
Tender offer solicitation
7:11am
June 5, 2023 through June 8, 2023, representatives of POINT met with representatives of Lilly while attending a healthcare conference, during which
SC TO-T
EX-99
PNT
POINT Biopharma Global Inc.
13 Oct 23
Third party tender offer statement
6:52am
of Lilly while attending a healthcare conference, during which representatives of Lilly indicated Lilly’s potential interest in the radiopharmaceuticals … served as chief counsel, corporate and securities at GE Healthcare from 2018 to 2019. Between 2015 and 2018, Mr. Anderson held various positions
ARS
2022 FY
PNT
POINT Biopharma Global Inc.
1 May 23
Annual report to shareholders
1:52pm
relationships with healthcare providers and physicians and third-party payors are subject to complex and extensive healthcare laws and regulations. ◦ Healthcare … , issuance by the FDA or other regulatory authorities of safety alerts, Dear Healthcare Provider letters, press releases or other communications
424B3
ixbvtw6fzl diq
11 Jul 22
Prospectus supplement
4:32pm
POS AM
97ki72ituv qhrb
1 Jul 22
Prospectus update (post-effective amendment)
4:17pm
DEF 14A
l1mr5naj2 2gj7c
28 Apr 22
Definitive proxy
8:36am
424B3
by88thju7unlw2rxy
31 Mar 22
Prospectus supplement
11:42am
POS AM
8q4iwrg
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
424B3
rj5lorv
5 Aug 21
Prospectus supplement
4:26pm
8-K
s93ufnu
21 Jun 21
Other Events
4:04pm
425
o8tskax4iak69i9rg
21 Jun 21
Business combination disclosure
4:02pm
424B3
iy1zacrik13oaq
9 Jun 21
Prospectus supplement
4:42pm
8-K
EX-99.1
2rj nqqg8f
9 Jun 21
Other Events
4:40pm
425
EX-99.1
4qqbb84omgpvhk6gekkp
9 Jun 21
Business combination disclosure
4:38pm